Literature DB >> 7963530

Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha.

M H Beaman1, C A Hunter, J S Remington.   

Abstract

Toxoplasma gondii is a major pathogen of immunocompromised hosts, and one defense mechanism against the parasite is activation of macrophages (M phi) for toxoplasmacidal activity by IFN-gamma after triggering by TNF-alpha. IL-6, IFN-gamma, and TNF-alpha are cytokines involved in inflammatory responses and are induced by T. gondii infection. We studied the interaction of these three cytokines using an in vitro model of T. gondii infection. Pretreatment (but not post-treatment) of unelicited murine peritoneal M phi with IL-6 enhanced T. gondii replication in a dose-dependent manner. Pretreatment with IFN-gamma resulted in active killing of parasites whereas the addition of IL-6 to IFN-gamma pretreatment resulted in a reversal of IFN-gamma-mediated toxoplasmacidal activity. Combining TNF-alpha with IL-6 and IFN-gamma pretreatment resulted in restoration of toxoplasmacidal activity. Addition of a polyclonal anti-TNF-alpha Ab to IL-6 and IFN-gamma pretreatment resulted in enhancement in the IL-6-mediated impairment of IFN-gamma function. These data taken together suggest that IL-6 enhances intracellular replication of T. gondii and reverses IFN-gamma mediated activation of murine peritoneal M phi, and that certain of the interactions between these two cytokines may be at the level of TNF-alpha triggering.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963530

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

2.  A critical role for SOCS3 in innate resistance to Toxoplasma gondii.

Authors:  Ryan J Whitmarsh; Carolyn M Gray; Beth Gregg; David A Christian; Michael J May; Peter J Murray; Christopher A Hunter
Journal:  Cell Host Microbe       Date:  2011-09-15       Impact factor: 21.023

3.  IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Authors:  Jonathan S Silver; Jason S Stumhofer; Sara Passos; Matthias Ernst; Christopher A Hunter
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

4.  Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.

Authors:  Y Suzuki; S Rani; O Liesenfeld; T Kojima; S Lim; T A Nguyen; S A Dalrymple; R Murray; J S Remington
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6.

Authors:  R E Lyons; J P Anthony; D J Ferguson; N Byrne; J Alexander; F Roberts; C W Roberts
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages.

Authors:  W E Peetermans; C J Raats; R van Furth; J A Langermans
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes.

Authors:  S K Halonen; F Chiu; L M Weiss
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection.

Authors:  Nina-N Pawlowski; Daniela Struck; Katja Grollich; Anja-A Kuhl; Martin Zeitz; Oliver Liesenfeld; Jorg-C Hoffmann
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.